| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDT | Ordinary Shares | +Grant/Award | $0 | +9,116 | +24.61% | $0.00 | 46,156 | Jul 31, 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDT | Performance Share Units | +Grant/Award | $0 | +22,790 | $0.00 | 22,790 | Jul 31, 2023 | Performance Share Unit | 22,790 | Direct | F3, F4, F5 | ||
| transaction | MDT | Stock Option (Right to Buy) | +Grant/Award | $0 | +64,185 | $0.00 | 64,185 | Jul 31, 2023 | Ordinary Shares | 64,185 | $87.76 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. |
| F2 | Includes 544 units acquired through dividend reinvestment and 310 units acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. |
| F3 | Each performance share unit represents a contingent right to receive one share of Medtronic common stock. |
| F4 | The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 22,790 shares will be issued. If maximum performance metrics are achieved, 45,580 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. |
| F5 | Vests on July 31, 2026. |
| F6 | These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. |